FIGHT: A randomized, double-blind, placebo-controlled, phase II study of bemarituzumab (bema) combined with modified FOLFOX6 in 1L FGFR2b+advanced gastric/gastroesophageal junction adenocarcinoma (GC).


Catenacci D. V. T., Kang Y., Saeed A., Yamaguchi K., Qin S., Lee K., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.15, 2021 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 39 Issue: 15
  • Publication Date: 2021
  • Doi Number: 10.1200/jco.2021.39.15_suppl.4010
  • Journal Name: JOURNAL OF CLINICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
  • Bezmialem Vakıf University Affiliated: No